Verified ComparisonLast updated: 13 April 2026
CJC-1295 + Ipamorelin vs Sermorelin
CJC-1295 + ipamorelin combines GHRH and ghrelin-receptor agonism with extended half-life. Sermorelin is a physiologic short-acting GHRH analog.
CJC-1295 + Ipamorelin
Growth Hormone
4.4/ 5
A
Sermorelin
GH Releasing
4.1/ 5
A−
Editor's note
Dual peptides offer synergy and longer activity; sermorelin is a simpler, shorter-acting alternative.
| Criterion | CJC-1295 + Ipamorelin | Sermorelin |
|---|---|---|
| Mechanism | GHRH + GHS-R (long-acting) | GHRH (short-acting) |
| Pathways | Dual | Single |
| Dosing frequency | Once or twice daily | Multiple daily injections |
| GH release pattern | Sustained with synergy | Pulsatile, physiologic |
| Regulatory status (AU) | Research-only | Defined indication |
Frequently asked questions
Dual peptides offer less-frequent dosing and dual-pathway synergy.
Want to read the full reviews?